Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 1901 publications
High-intensity Focused Ultrasound (HIFU) Therapy Market by Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others) - Global Opportunity Analysis... US$ 5,370.00

High-intensity focused ultrasound (HIFU) is a precise medical procedure, which applies high-intensity focused ultrasound energy to locally heat and destroy damaged or diseased tissue through ablation. In this therapy, ultrasound beams are focused on diseased ...

Jun, 2018 135 pages
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Cancer, Genetic Disorders, Infectious Diseases, CVD, Neuro Disorders), By Vector Type (Viral, Non-Viral), By... US$ 5,950.00

The global gene therapy market size is expected to reach USD 39.54 million by 2026. Rising competition among manufacturers ... better efficacy as compared to gene therapy alone. Cancer held the dominant share in the market in 2017 owing to relatively high adoption of gene therapies for cancer treatment. Continual ...

May, 2018 120 pages
Leukemia Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00 US$ 4,316.00

... REPORT DELIVERS? 1. Comprehensive analysis of global as well as regional markets of leukemia therapeutics market. 2. Complete coverage of all the segments in leukemia therapeutics market to analyze the trends, developments in the global ...

May, 2018 100 pages
Infantile Spasms Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00 US$ 4,316.00

... COVERED The global infantile spasms therapeutics market is segmented on the basis of dosage and route of administration. Global Infantile Spasms Therapeutics Market by Dosage Solid Liquid Global Infantile Spasms Therapeutics Market by Route of Administration Oral ...

May, 2018 100 pages
Hospital Infection Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00 US$ 4,316.00

... hospital infection therapeutics market is segmented on the basis of by drug type and by major infections. Global Hospital Infection Therapeutics Market by Drug Type Antibacterial Drugs Antiviral Drugs Antifungal Drugs Global Hospital Infection Therapeutics Market by Major Infections Hospital ...

May, 2018 100 pages
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market US$ 4,995.00

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market SUMMARY Psoriasis is a common, chronic inflammatory skin ... people with psoriasis eventually develop psoriatic arthritis. Psoriasis is a serious skin condition that has ...

Jun, 2018 125 pages
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals US$ 2,538.00

... less successful against solid tumors. This report „TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & ... acquisition prices and financing rounds. Download Sample Pages: TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders ...

May, 2018 294 pages
Global CNS Therapeutics Market 2018-2022 US$ 3,500.00 US$ 2,500.00

... on geography: Americas APAC EMEA Technavio's report, Global CNS Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The ...

May, 2018 104 pages
Global Chemotherapy-induced Neutropenia Therapeutics Market 2018-2022 US$ 3,500.00 US$ 2,500.00

... the present scenario and the growth prospects of the global chemotherapy-induced neutropenia therapeutics market. To calculate the market size, the report considers the revenue generated from ...

May, 2018 102 pages
Global Brachytherapy Therapy Market 2018-2024 US$ 2,750.00

Global Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves ...

Mar, 2018 99 pages
Protein Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00 US$ 4,316.00

... The global protein therapeutics market is segmented on the basis of protein function and product type. Global Protein Therapeutics Market by Protein Function Vaccines Enzymatic And Regulatory Protein Diagnostics Global Protein Therapeutics Market by Product ...

Mar, 2018 100 pages
Gout Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00 US$ 4,316.00

... REPORT DELIVERS? 1. Comprehensive analysis of global as well as regional markets of gout therapeutics market. 2. Complete coverage of all the segments in gout therapeutics market to analyze the trends, developments in the global ...

Mar, 2018 100 pages
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies US$ 4,995.00

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies SUMMARY Hereditary Angioedema (HAE) is a rare genetic disorder ... fluids to build up in body tissues (edema). The onset of HAE may occur at any age but is ...

Mar, 2018 92 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Apr, 2018 529 pages
Global Cell Therapy Market, Price, Product & Clinical Pipeline Outlook 2024 US$ 2,400.00

... potential. Kuick Research Report on the Global cell therapy market provides a detailed insight into the current scenario of the cell therapy market worldwide. Key data like pricing of cell therapy products, cost analysis of cell therapy ...

Apr, 2018 1200 pages
Microbiome-Targeted Therapeutics in Immunology US$ 7,995.00

Microbiome-Targeted Therapeutics in Immunology SUMMARY Flares in gastrointestinal and dermatology indications are characterized by a shift in the proportion of bacterial species in either the gut or skin microbiome ... shaping and driving the global microbiome market in immunology. Formulate effective sales and ...

Mar, 2018 78 pages
Global Peptide Therapeutics Market Report 2018 US$ 2,350.00

... maintained a relatively optimistic growth, the past four years, Peptide Therapeutics market size to maintain the average annual growth rate of ... next few years, Peptide Therapeutics market size will be further expanded, we expect that by 2022, The market size of the Peptide Therapeutics will reach 40 million ...

Apr, 2018 124 pages
Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022 US$ 3,500.00 US$ 2,500.00

ABOUT POST-TRAUMATIC STRESS DISORDER (PTSD) THERAPEUTICS PTSD) therapeutics include drugs that are used in the treatment of PTSD. Technavio’s analysts forecast the global post-traumatic stress disorder (PTSD) therapeutics market to grow at a CAGR of 1.26% during ...

Mar, 2018 116 pages
Negative Pressure Wound Therapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 US$ 4,795.00 US$ 4,316.00

... -use NPWT Devices Global Negative Pressure Wound Therapy Market by Wound Type Diabetic Foot Ulcers Venous Leg Ulcers Pressure Ulcers Burn Wounds Others Global Negative Pressure Wound Therapy Market by End Use Hospitals ...

Mar, 2018 100 pages
Metabolic Disorders Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 US$ 4,795.00 US$ 4,316.00

... global metabolic disorders therapeutics market is segmented on the basis of disease type and product. Global Metabolic Disorders Therapeutics Market by Disease Type Diabetes Obesity Hypercholesterolemia Lysosomal Storage Disease Global Metabolic Disorders Therapeutics Market ...

Mar, 2018 100 pages
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H1 2018 US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) development landscape Develop and design in-licensing and ...

Apr, 2018 51 pages
Exploring Opportunities in Niche Therapies – Human Cytomegalovirus (HCMV) Infections US$ 2,500.00

... for these patients. In this report we discuss the recently approved therapies for CMV infections, other drugs and vaccines in the pipeline ...

Apr, 2018 42 pages
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs US$ 4,995.00

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs SUMMARY Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Mar, 2018 148 pages
Global Microbiome Therapeutics Market Report 2018 US$ 2,350.00

... maintained a relatively optimistic growth, the past four years, Microbiome Therapeutics market size to maintain the average annual growth rate of ... next few years, Microbiome Therapeutics market size will be further expanded, we expect that by 2022, The market size of the Microbiome Therapeutics will reach 80 ...

Apr, 2018 119 pages
Cell Therapy Processing: Global Markets and Technologies US$ 4,950.00

... in-depth analysis of the global cell therapy processing market by offering type, application and geographic regional markets. The report includes key inhibitors ... in the global cell therapy processing market. In-depth patent analysis in the report will provide extensive technological trends across years ...

Mar, 2018 187 pages
Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018 US$ 2,000.00

... . The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Mar, 2018 260 pages
Japan Proton Therapy Market, Patients by10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic,... US$ 1,400.00

... and planning phase. Report also provides Japan proton therapy reimbursement policies. By Cancer Type - Japan Proton Therapy Market & Patient Numbers In proton therapy, the frequency of patients is much higher in prostate cancer because of its ...

Mar, 2018
Achondroplasia - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Mar, 2018 43 pages
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018 US$ 3,500.00

... Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Mar, 2018 58 pages
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market US$ 4,995.00

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market SUMMARY Uveitis refers to inflammation of the uvea, the middle vascular coat ...

Feb, 2018 91 pages
The 2019-2024 World Outlook for Therapeutic Plasma Exchange (TPE) Solutions US$ 995.00

This study covers the world outlook for therapeutic plasma exchange (TPE) solutions across more than 190 countries. For each year ... demand, or the P.I.E., for therapeutic plasma exchange (TPE) solutions. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

Jan, 2018 274 pages
The 2019-2024 World Outlook for Therapeutic Beds US$ 995.00

This study covers the world outlook for therapeutic beds across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for therapeutic beds. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Regenerative Therapies US$ 995.00

This study covers the world outlook for regenerative therapies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for regenerative therapies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Pruritus Therapeutics US$ 995.00

This study covers the world outlook for pruritus therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for pruritus therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Oxygen Therapies US$ 995.00

This study covers the world outlook for oxygen therapies across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for oxygen therapies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Dementia and Movement Disorder Therapeutics US$ 995.00

This study covers the world outlook for dementia and movement disorder therapeutics across more than 190 countries. For each year ... , or the P.I.E., for dementia and movement disorder therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

Jan, 2018 278 pages
The 2019-2024 World Outlook for Asthma Therapeutics US$ 995.00

This study covers the world outlook for asthma therapeutics across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for asthma therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Antisense and RNA Interference (RNAi) Therapeutics US$ 995.00

This study covers the world outlook for antisense and RNA interference (RNAi) therapeutics across more than 190 countries. For each ... or the P.I.E., for antisense and RNA interference (RNAi) therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, ...

Jan, 2018 279 pages
Global Gene Therapy Market Analysis & Forecast to 2022 US$ 4,900.00

... therapeutic genes? Where is the gene therapy market heading, and what opportunities and challenges will it face? EXECUTIVE SUMMARY Growing at a CAGR of over x% the global gene therapy market ... reimbursement and its high cost. This 310 page market analysis cutting-edge report tackles this growing but challenging ...

Mar, 2017 310 pages
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H1 2018 US$ 3,500.00

... Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Feb, 2018 70 pages
Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H1 2018 US$ 3,500.00

... Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Feb, 2018 33 pages
Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H1 2018 US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) development landscape Develop and ...

Feb, 2018 70 pages
Global Gene Therapy Market Report 2018 US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Gene Therapy market size to maintain the average annual growth rate of 6.62% from ... in the next few years, Gene Therapy market size will be further expanded, we expect that by 2022, The market size of the Gene Therapy will reach 1265 million ...

Feb, 2018 130 pages
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or... US$ 3,500.00

... /Universities. It also reviews key players involved in E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) targeted therapeutics development with respective active ...

Feb, 2018 74 pages
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase... US$ 3,500.00

... reviews key players involved in Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) targeted therapeutics development with respective ...

Feb, 2018 35 pages
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis US$ 2,995.00

... SUMMARY GBI Research’s latest report: “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties ... as Glybera and Strimvelis” discusses all gene therapies, including not only those which involve genetic modification, but also RNAi, CAR-T ...

Jan, 2018 79 pages
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2018 US$ 3,500.00

... Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Feb, 2018 72 pages
Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2018 US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) development landscape Develop ...

Feb, 2018 64 pages
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2018 US$ 3,500.00

... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Feb, 2018 62 pages
Japan Proton Therapy Market Research Report 2018 US$ 1,100.00

... ) Japan Proton Therapy Reimbursement Scenario Proton Therapy Center Component Analysis Proton Therapy Clinical Trail Insight by Phase, Institute & Country Proton Therapy Market – Major Deals Key Market Drivers and Inhibitors of the Japan Proton Therapy Market ...

Feb, 2018 110 pages
1 2 3 4 5 >
Skip to top